Decreased liver peroxisomal β-oxidation accompanied by changes in brain fatty acid composition in aged rats

Neurological Sciences

Volumn 35, Issue 2, 2014, Pages 289-293

  Yang, Lei ^a   Zhang, Yu ^a   Wang, Shasha ^a   Zhang, Wei ^a   Shi, Ruling ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Acyl CoA oxidase 1; Brain aging; Fatty acid oxidation; Peroxisome; Very long chain fatty acids

Indexed keywords

ACYL-COA OXIDASE; AGING; ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CHROMATOGRAPHY, GAS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; LIVER; MALE; OXIDATION-REDUCTION; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84893827588     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1509-3     Document Type: Article

References (22)

1. Van Veldhoven PP (2010) Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 51:2863-2895. doi: 10.1194/jlr.R005959
2. Ferdinandusse S, Denis S, Mooijer PA et al (2001) Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res 42:1987-1995 (Pubitemid 34001047)
3. Glosli H, Gudbrandsen OA, Mullen AJ et al (2005) Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha. Biochim Biophys Acta 1734:235-246 (Pubitemid 40805080)
4. Périchon R, Bourre JM (1995) Peroxisomal β-oxidation activity and catalase activity during development and aging in mouse liver. Biochimie 77:288-293
5. Périchon R, Bourre JM (1996) Aging-related decrease in liver peroxisomal fatty acid oxidation in control and clofibrate-treated mice. A biochemical study and mechanistic approach. Mech Ageing Dev 87:115-126 (Pubitemid 26164286)
6. Sanguino E, Roglans N, Alegret M et al (2005) Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4. Br J Pharmacol 145:853-861 (Pubitemid 41129006)
7. Carver JD, Benford VJ, Han B et al (2001) The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull 56:79-85 (Pubitemid 33028885)
8. Favrelère S, Stadelmann-Ingrand S, Huguet F et al (2000) Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging 21:653-660
9. Giusto NM, Salvador GA, Castagnet PI et al (2002) Age-associated changes in central nervous system glycerolipid composition and metabolism. Neurochem Res 27:1513-1523 (Pubitemid 36014163)
10. Ulmann L, Mimouni V, Roux S et al (2001) Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot Essent Fatty Acids 64:189-195 (Pubitemid 32896820)
11. Yetimler B, Ulusoy G, Çelik T et al (2012) Differential effect of age on the brain fatty acid levels and their correlation with animal cognitive status in mice. Pharmacol Biochem Behav 103:53-59
12. Cunnane SC, Chouinard-Watkins R, Castellano C et al (2013) Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids 88:61-70. doi: 10.1016/j.plefa.2012.04.006
13. Cunnane SC, Schneider JA, Tangney C et al (2012) Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 29:691-697. doi: 10.3233/JAD-2012-110629
14. Fabelo N, Martín V, Santpere G et al (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med 17:1107-1118. doi: 10.2119/molmed.2011. 00119
15. Fraser T, Tayler H, Love S (2010) Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 35:503-513. doi: 10.1007/s11064-009-0087-5
16. Kou J, Kovacs GG, Höftberger R et al (2011) Peroxisomal alterations in Alzheimer's disease. Acta Neuropathol 122:271-283. doi: 10.1007/s00401-011- 0836-9
17. Martín V, Fabelo N, Santpere G et al (2010) Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J Alzheimers Dis 19:489-502. doi: 10.3233/JAD-2010-1242
18. Bourre JM, Piciotti M (1997) Alterations in eighteen-carbon saturated, monounsaturated and polyunsaturated fatty acid peroxisomal oxidation in mouse brain during development and aging. Biochem Mol Biol Int 41:461-468 (Pubitemid 27154125)
19. Latruffe N, Cherkaoui Malki M, Nicolas-Frances V et al (2000) Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochem Pharmacol 60:1027-1032
20. Fanelli F, Sepe S, D'Amelio M et al (2013) Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol Neurodegener 8:8. doi: 10.1186/1750-1326-8-8
21. Shi R, Zhang Y, Shi Y et al (2012) Inhibition of peroxisomal β-oxidation by thioridazine increases the amount of VLCFAs and Aβ generation in the rat brain. Neurosci Lett 528:6-10. doi: 10.1016/j.neulet.2012. 08.086
22. Alexson SE, Cannon B (1984) A direct comparison between peroxisomal and mitochondrial preferences for fatty-acyl beta-oxidation predicts channelling of medium-chain and very-long-chain unsaturated fatty acids to peroxisomes. Biochim Biophys Acta 796:1-10